Equities

GSK plc

GSK:LSE

GSK plc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,330.50
  • Today's Change21.00 / 1.60%
  • Shares traded1.75m
  • 1 Year change-5.72%
  • Beta0.6040
Data delayed at least 20 minutes, as of Nov 22 2024 12:30 GMT.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue30,32829,32424,696
OPERATING EXPENSES
Cost of revenue total8,3638,4678,006
Selling, general and admin. expenses, total9,0298,1286,749
Depreciation/amortization7291101
Unusual expense(income)897529355
Other operating expenses, total(1190)(819)(434)
Total operating expense23,58222,89120,375
Operating income6,7466,4334,321
Other, net(48)(799)561
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6,0645,6283,599
Provision for income taxes75670783
Net income after taxes5,3084,9213,516
Minority interest(380)(665)(711)
Net income before extra. Items4,9284,2562,805
Total extraordinary items010,7001,580
Net income4,92814,9564,385
Inc.avail. to common excl. extra. Items4,9284,2562,805
Inc.avail. to common incl. extra. Items4,92814,9564,385
EPS RECONCILIATION
Basic/primary weighted average shares4,0524,0264,003
Basic/primary eps excl. extra items1.221.060.70
Basic/primary eps incl. extra items1.223.711.10
Dilution adjustment------
Diluted weighted average shares4,1114,0844,052
Diluted eps excl. extra items1.201.040.69
Diluted eps incl. extra items1.203.661.08
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.580.611.00
Gross dividend - common stock2,3522,4704,006
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental710819762
SUPPLEMENTAL INCOME
Depreciation, supplemental1,0821,0611,195
Total special items1,187687636
NORMALISED INCOME
Normalized income before taxes7,2516,3154,235
Effect of special items on income taxes347281682
Income tax excluding impact of special items1,103988765
Normalized income after tax6,1485,3273,470
Normalized income avail. to common5,7684,6622,759
Basic normalized EPS1.421.160.69
Diluted normalized EPS1.401.140.68
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.